<DOC>
	<DOCNO>NCT00904397</DOCNO>
	<brief_summary>Patients axial low back pain ( LBP ) without radiation present least 3 month daily moderate severe LBP primary source pain participate Phase IV clinical trial ass efficacy lidocaine patch 5 % compare celecoxib 200 mg treat chronic axial LBP without radiation .</brief_summary>
	<brief_title>Lidocaine Patch 5 % Versus Celecoxib 200 mg Chronic Axial Low Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>1 . Had axial LBP without radiation present least 3 month define : Chronic axial LBP without radiation : pain isolate axial low back without radiation buttock Chronic axial LBP radiation : pain radiate buttock . This patient group could include patient radicular/neuropathic nonradicular component leg pain component &lt; 50 % 2 . Had daily moderate severe LBP primary source pain 3 . Had normal neurological examination , include : Motor strength Sensory exam low extremity Deep tendon reflexes 4 . Had normal 12lead electrocardiogram ( ECG ) without clinically significant abnormality heart rate , rhythm , conduction 5 . Had discontinue use analgesic medication ( include overthecounter [ OTC ] analgesic ) , glucosamine , chondroitin prior randomization ( patient allow limited use analgesic medication indication nonstudy pain 6 . At baseline visit , patient randomize active treatment average daily pain intensity score 5 great ( 0 10 scale ) least 3 day 5 consecutive day immediately prior baseline visit ; 0 define `` pain '' 10 define `` pain bad ever imagine '' measure Question 5 Brief Pain Inventory ( BPI ) record diary 1 . Had spinal stenosis &gt; 50 % leg pain component 2 . Had chronic pain condition , opinion investigator , would interfere patient assessment LBP relief 3 . Had history one back surgery within 1 year study entry 4 . Had moderate great hepatic impairment 5 . Had severe renal insufficiency ( creatinine clearance &lt; 30 mL/min ) 6 . Had experience asthma , urticaria , allergictype reaction take aspirin nonsteroidal antiinflammatory drug ( NSAIDs ) 7 . Had prior history peptic ulcer disease and/or gastrointestinal ( GI ) bleed 8 . Were take analgesic medication could discontinue study . Patients take medication prior study require discontinue use duration study . Patients use opioid analgesic study entry require taper medication . 9 . Were take longacting opioids opioids could discontinue first 5 day washout period 10 . Were receive fluconazole lithium ( secondary drugdruginteraction risk celecoxib ) 11 . Had receive epidural steroid/local anesthetic injection within 4 week prior study entry 12 . Had receive trigger point injection within 2 week prior study entry 13 . Had receive Botulinum Toxin ( Botox ) injection LBP within 6 month prior study entry 14 . Were use lidocainecontaining product discontinue study 15 . Were use topical medication apply low back region 16 . Had previously fail treatment Lidoderm analgesic patch LBP 17 . Had previously fail treatment celecoxib two COX2 specific inhibitor celecoxib 18 . Were take class I antiarrhythmic ( e.g . mexiletine , tocainide ) 19 . Had history alcohol substance abuse within last 3 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>